SCHEMBL22476540

SCHEMBL22476540

Cn1cnc2c1C(=O)N[SH](C)(=O)NC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21987948 0.64 DRD4 (0.43)
SCHEMBL24328585 0.58 DRD4 (0.51)
SCHEMBL21030280 0.57 GDA (0.33)
SCHEMBL20011085 0.56 GDA (0.32)
SCHEMBL31651687 0.54
SCHEMBL21363443 0.54 SRC (0.38)
SCHEMBL17761950 0.54 GDA (0.33)
SCHEMBL10104855 0.53 GDA (0.32)
SCHEMBL6860784 0.52 GDA (0.31)
SCHEMBL14091653 0.52 GDA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3714888-A1 COMPOUNDS FOR USE IN THE TREATMENT OF ADCY5-RELATED DYSKINESIA ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) 2020-09-30 EP disclosed